Short term treatment of Paget's disease with porcine calcitonin
Renier, J.C.; Boasson, M.; Jallet, P.; Bernat, M.
Revue du Rhumatisme et des Maladies Osteo-Articulaires 40(10): 557-563
1973
ISSN/ISBN: 0035-2659 PMID: 4797550 Document Number: 65117
Document emailed within 1 workday
Related Documents
Dube, W.J.; Goldsmith, R.S.; Arnaud, S.B.; Arnaud, C.D. 1973: Development of antibodies to porcine calcitonin during treatment of Paget's disease of bone Mayo Clinic Proceedings 48(1): 43-46Tarquini, B.; Ciapini, A.; Benvenuti, M.; Moretti, R.; Cherici, R.; Comparini, T.; Neri, B. 1980: Chronopharmacological effect of porcine calcitonin in Paget's disease of the bone La Clinica Terapeutica 94(6): 659-670
Courvoisier, B.; de Barros, Q.; Jacot, C.; Zender, R. 1970: Acute effect of porcine calcitonin in persons without osteopathy and patients with Paget's disease Schweizerische Medizinische Wochenschrift 100(1): 26-32
Manderlier, T.; Fuss, M.; Brauman, J.; Orloff, S.; Bergans, A.; Corvilain, J. 1976: Treatment of Paget's disease of bone with salmon calcitonin Acta Clinica Belgica 31(6): 329-338
Ghiringhelli, G.; Fogel, M.; Varela de Rodríguez, J.; Casco, C.; Mautelén, C.; Nusimovich, B. 1982: Treatment of Paget's disease with the combined administration of calcitonin and disodium etidronate Medicina 42(1): 16-20
Miravet, L.; Kuntz, D. 1989: Amino-hydroxy-propylidene biphosphonate in the treatment of Paget's disease resistant to calcitonin and/or etidronate Revue du Rhumatisme et des Maladies Osteo-Articulaires 56(4): 287-292
Detilleux, M.; Guillausseau, P.J.; Caquet, R.; Reynaud, M.; Metzger, J.; Askienazy, S.; Laroche, C. 1977: Paget's disease with obstructive communicating hydrocephalus and dementia. Favorable outcome under the treatment with calcitonin Annales de Medecine Interne 128(8-9): 667-672
Louyot, P.; Pourel, J. 1974: Paget's disease and calcitonin. Personal experience Acta Orthopaedica Belgica 40(4): 538-545
Luboshitzky, R.; Bar-Shalom, R. 1995: Calcitonin nasal spray for Paget's disease of the bone Harefuah 128(6): 358-362; 399
Pembrook, R.C.; Chung, C.H.; Carvallo, A.P. 1975: Effects of mithramycin and calcitonin in cardiovascular complications of Paget's disease of bone Connecticut Medicine 39(4): 209-214
Wenz, W.; Basler, L. 1985: Significance of x-ray diagnosis in the control of calcitonin therapy of Paget's disease: case report Der Radiologe 25(12): 594-596
Epstein, S.; Owen, G. 1977: Paget's disease of bone (osteitis deformans) treated with human synthetic calcitonin South African Medical Journal 51(5): 133-137
Lo Cascio, V.; Lechi, C.; Adami, S.; Bianchi, I.; Cominacini, L.; Galvanini, G. 1974: Comparative studies of the behavior of blood calcium and urinary hydroxyproline after infusion of calcitonin and glucagon in patients with Paget's disease Bollettino della Societa Italiana di Biologia Sperimentale 50(1-2): 55-61
Apperloo, A.J.; de Zeeuw, D.; de Jong, P.E. 1994: Short-term antiproteinuric response to antihypertensive treatment predicts long-term GFR decline in patients with non-diabetic renal disease Kidney International. Suppl 45: S174-S178
Body, G.; Granger, M.; Fetissoff, F.; Lansac, J. 1982: Paget's disease of the vulva associated with Paget's disease of the breast. Apropos of a case report. Review of the literature Journal de Gynecologie Obstetrique et Biologie de la Reproduction 11(7): 815-821
Song, Y.; Kang, X.M.; Xia, X.R. 1993: Clinical observation on short term nutritional support in the treatment of advanced chronic obstructive pulmonary disease Zhonghua Nei Ke Za Zhi 32(12): 819-822
García Villarreal, L.; Zozaya, J.M.; Macías, E.; García González, N.; Quiroga, J.; Conchillo, F.; Prieto, J. 1991: The treatment of primary biliary cirrhosis with ursodeoxycholic acid. the short- and median-term results and their relation to the study of the disease Revista Espanola de Enfermedades Digestivas: Organo Oficial de la Sociedad Espanola de Patologia Digestiva 80(5): 311-315
Nicolle, M.H.; Grondard, E.; François, N.; Maury, M. 1977: Paget's paraplegia, treated successfully with calcitonin, with remission lasting over 3 years La Nouvelle Presse Medicale 6(18): 1567
Traianos, A.; Vavilis, D.; Makedos, A.; Karkanaki, A.; Ravanos, K.; Prapas, N.; Tarlatzis, B.C. 2013: Effect of short-term tibolone treatment on risk markers for cardiovascular disease in healthy postmenopausal women: a randomized controlled study Clinical and Experimental Obstetrics and Gynecology 40(4): 542-545
Anttila, L.; Koskinen, P.; Erkkola, R.; Irjala, K.; Ruutiainen, K. 1994: Serum testosterone, androstenedione and luteinizing hormone levels after short-term medroxyprogesterone acetate treatment in women with polycystic ovarian disease Acta Obstetricia et Gynecologica Scandinavica 73(8): 634-636